close
close

Clear overview of the Daratumumab combination in Multiple Myeloma

Posted on by Vaseline


Therapy time data



A quadruple therapy with anti-daratumumab for a stem transplant recipient who received Daratumumab as a maintenance therapy for multiple myeloma has not progressed any further and has become less rapid.

Related Posts